Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (<i>S</i>)-CE-123 on Mesocorticolimbic Dopamine System
Treatments for cognitive impairments associated with neuropsychiatric disorders, such as attention deficit hyperactivity disorder or narcolepsy, aim at modulating extracellular dopamine levels in the brain. CE-123 (5-((benzhydrylsulfinyl)methyl) thiazole) is a novel modafinil analog with improved sp...
Main Authors: | Claudia Sagheddu, Nicholas Pintori, Predrag Kalaba, Vladimir Dragačević, Gessica Piras, Jana Lubec, Nicola Simola, Maria Antonietta De Luca, Gert Lubec, Marco Pistis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/5/779 |
Similar Items
-
Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry
by: Predrag Kalaba, et al.
Published: (2023-09-01) -
Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution
by: Iva Spreitzer, et al.
Published: (2023-11-01) -
Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors
by: Melinda Hersey, et al.
Published: (2023-07-01) -
Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation
by: Kevin D Lominac, et al.
Published: (2014-05-01) -
The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze
by: Yasemin eKarabacak, et al.
Published: (2015-08-01)